The Pharmacy Times® Cardiovascular Health resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Study Shows Consistent Efficacy, Safety of Inclisiran in Lowering Low-Density Lipoprotein Cholesterol
An analysis of phase 3 study data found that 99% of patients who received inclisiran showed a significant placebo-adjusted reduction in low-density lipoprotein cholesterol (LDL-C).
Athletes and endurance athletes are at an increased risk of atrial fibrillation.
The UK Stroke Association noted that rather than focusing on fish oil, individuals should eat fresh foods low in salt and sugar, such as fruits and vegetables, and rich in fiber, such as brown varieties of bread and pasta.
Study: Evolocumab Significantly Reduces LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Evolocumab in combination with statins and other lipid-lowering therapies was found to significantly reduce low-density lipoprotein cholesterol in pediatric patients with heterozygous familial hypercholesterolemia.
This is the first study to systematically investigate whether individual blood pressure medications might influence the risk of developing depression, according to the authors.
Women on Beta Blockers for Hypertension May Have Higher Risk of Heart Failure Than Men When Presenting With Acute Coronary Syndrome
Women prescribed beta blockers for hypertension who have no history of cardiovascular disease have a 4.6% greater risk of heart failure than men when experiencing acute coronary syndrome.
The study findings underscore the importance of medication adherence, an issue in which pharmacists can play a major role in the patients' lives.
Patients with peripheral artery disease and depressive symptoms experience worse recovery than patients without depressive symptoms.
There is no greater support team available to students than their pharmacy school.
Symptoms of polycystic ovary syndrome, such as obesity and diabetes, can lead to a 19% higher risk of heart disease.
The death rate for patients who experienced a normally lower-risk heart attack rose sharply during the peak of the coronavirus disease 2019 pandemic.
Treatment of peripheral artery disease and coronary artery disease must be optimized to allow patients to maintain their regular life activities.